Psoriasis Clinical Trial

A Study of LY3041658 in Participants With Skin Diseases

Summary

The main purpose of this study is to investigate the safety and tolerability of the study drug known as LY3041658 in participants with certain types of skin diseases. The study will measure how the body absorbs, breaks down and gets rid of LY3041658. It will last about 127 days for each participant, not including screening. This study is for research purposes only, and is not intended to treat any medical condition.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Investigator confirmed diagnosis of certain skin diseases for at least 6 months.
Active skin lesions that are not responding to standard therapies.
Willing to undergo pre- and post-treatment skin biopsies of lesions.

Exclusion Criteria:

- Have other skin diseases that may interfere with evaluation of the specified skin disease being studied.

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

60

Study ID:

NCT02896868

Recruitment Status:

Completed

Sponsor:

Eli Lilly and Company

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

Parexel Early Phase Unit at Glendale
Glendale California, 91206, United States
Dawes Fretzin Clinical Research
Indianapolis Indiana, 46256, United States
PAREXEL-Phase 1 Baltimore Harbor Hospital Center
Baltimore Maryland, 21225, United States
Duke University Medical Center
Durham North Carolina, 27710, United States
Altoona Center for Clinical Research
Duncansville Pennsylvania, 16635, United States

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 1

Estimated Enrollment:

60

Study ID:

NCT02896868

Recruitment Status:

Completed

Sponsor:


Eli Lilly and Company

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider